Equity Research, Broker Reports, and media content on Shield Therapeutics

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Shield Therapeutics
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Shield Therapeutics. We currently have 88 research reports from 8 professional analysts.

Open
186p
Range Today
182/186p
52 Week
30.5/196p
Daily Volume
38.5k
# Shares
117.2m
Daily Liquidity
(0.03%)
Pension Liability
£0m
Enterprise Value
£78.1m
Market Cap
£215.0m
Latest PE (hist)
Div Yield
Date Source Announcement
02Sep19 09:14 EQS Hardman & Co Research: Shield Therapeutics (STX): FDA approval ushers in a new era for Shield
29Aug19 07:00 RNS-R Investor presentations
15Aug19 10:17 RNS Director/PDMR Shareholding
07Aug19 07:00 RNS Half-year Report
05Aug19 11:22 EQS Hardman & Co Research: Shield Therapeutics (STX) FDA approval opens door to major US opportunity
31Jul19 13:21 RNS Notice of Results
26Jul19 14:05 RNS Second Price Monitoring Extn
  • Frequency of research reports

     

  • Research reports on

    Shield Therapeutics

  • Providers covering

    Shield Therapeutics